FDA Adverse Event Injury Summary report: N

CORDELLA PULMONARY ARTERY SENSOR SYSTEM

MDR report key: 19849858 · Received July 29, 2024

Report

Report Number
3024985933-2024-00002
Event Type
Injury
Date Received
July 29, 2024
Date of Event
July 1, 2024
Report Date
May 14, 2025
Manufacturer
ENDOTRONIX, INC
Product Code
MOM
PMA / PMN Number
P230040
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE SENSOR WAS NOT RETURNED FOR EVALUATION AS IT REMAINS IMPLANTED. THE DEVICE HISTORY RECORD (DHR) FOR THE SENSOR LOT WAS REVIEWED AND IT WAS CONFIRMED THAT ALL MANUFACTURING OPERATIONS AND INSPECTIONS WERE PERFORMED, ALL ACCEPTANCE CRITERIA WERE MET, AND NO RELEVANT NONCONFORMANCES WERE ASSOCIATED WITH THE SENSOR LOT AT THE TIME OF MANUFACTURE. ON (B)(6) 2024 THE PATIENT UNDERWENT A RIGHT HEART CATHETERIZATION (RHC) RECALIBRATION. THE RECALIBRATION CONFIRMED THAT THE SENSOR ACCURACY FALLS WITHIN THE ACCEPTABLE BETWEEN THE CORDELLA SYSTEM AND FLUID-FILLED REFERENCE MEASUREMENT. BASED ON THE EVIDENCE, THE REPORTED COMPLAINT OF INACCURATE MEASUREMENT THERE WAS NO FAILURE DETECTED; THE SYSTEM WAS FOUND TO BE PERFORMING AS INTENDED AND WITHIN THE EXPECTED ACCURACY LIMITS.

Additional Manufacturer Narrative · 0

NO DEVICE ANALYSIS RESULTS ARE AVAILABLE BECAUSE THE DEVICE REMAINS IMPLANTED, HOWEVER, THE ACTUAL DEVICE WAS EVALUATED VIA RHC. PER THE IFU, RHC IS REQUIRED TO RECALIBRATE THE SENSOR IF SENSOR INACCURACY IS SUSPECTED. ADDIITONAL INFORMAITON WILL BE SUBMITTED WITHIN 30 DAYS OF RECEIPT.

Additional Manufacturer Narrative · 0

CORRECTED DATA: SECTION G3: INITIAL REPORT DATE RECEIVED BY MANUFACTURER.

Description of Event or Problem · 0

A RHC WAS PERFORMED TO RECALIBRATE THE PRESSURE SENSOR AGAINST A REFERENCE PRESSURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
897262 CORDELLA PULMONARY ARTERY SENSOR SYSTEM PULMONARY ARTERY SENSOR MOM ENDOTRONIX, INC

Patients

Seq Age Sex Outcome Treatment
1 NA Male Required Intervention LOSARTAN| LVAD IMPLANT| TORSEMIDE 20MG/DAY